Moreno, V., et al. “Effect of Oral Contraceptives on Risk of Cervical Cancer in Women with Human Papillomavirus Infection: The IARC Multicentric Case-Control Study”. Lancet 359, no. 9312 (2002): 1085–92.

Murray, E. K. I., et al. “Thromboelastographic Identifies Cyclic Haemostatic Variations in Healthy Women Using Oral Contraceptives”. Thrombosis Research 136, no. 5 (2015): 1022–26.

Nestler, J. E., et al. “Ovulatory and Metabolic Effects of D-chiro-inositol in the Polycystic Ovary Syndrome”. New England Journal of Medicine 340, no. 17 (1999): 1314–20.

Nightingale, A. L., et al. “The Effects of Age, Body Mass Index, Smoking, and General Health on the Risk of Venous Thromboembolism in Users of Combined Oral Contraceptives”. European Journal of Contraception and Reproductive Health Care 5, no. 4 (2000): 265–74.

Nordio, M., et al. “The Combined Therapy with Myo-inositol and D-chiro-inositol Reduces the Risk of Metabolic Disease in PCOS Overweight Patients Compared to Myo-inositol Supplementation Alone”. European Review for Medical and Pharmacological Sciences 16, no. 5 (2012): 575–81.

Oner, G., et al. “Clinical, Endocrine, and Metabolic Effects of Metformin vs. N-Acteylcytseine in Women with Polycystic Ovary Syndrome”. European Journal of Obstetrics, Gynecology, and Reproductive Biology 159, no. 1 (2011): 127–31.

“Oral – Contraceptive Use and the Risk of Breast Cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development”. New England Journal of Medicine 315, no. 7 (1986): 405–11.

Orio, F., et al. “Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome”. Minerva Ginecologica 60, no. 1 (2008): 39–51.

Pelusi, B., et al. “Type 2 Diabetes and the Polycystic Ovary Syndrome”. Minerva Ginecologica 56, no. 1 (2004): 41–51.

Pomp, E. R., et al. “Risk of Venous Thrombosis: Obesity and Its Joint Effect with Oral Contraceptive Use and Prothrombotic Mutations”. British Journal of Haematology 139, no. 2 (2007): 289–96.

Raghuramulu, N., et al. “Vitamin D Improves Oral Glucose Tolerance and Insulin Secretion in Human Diabetes”. Journal of Clinical Biochemistry and Nutrition 13, no. 1 (1992): 45–51.

Raitakari, M., et al. “Distribution and Determinants of Serum High-Sensitive C-Reactive Protein in a Population of Young Adults: The Cardiovascular Risk in Young Finns Study”. Journal of Internal Medicine 258, no. 5 (2005): 428–34.

Roach, R. E., et al. “Combined Oral Contraceptives: The Risk of Heart Attack and Stroke in Women Using Birth Control Pills”. Cochrane Database of Systematic Reviews no. 8 (2015): CD011054. Roberfroid, M., et al. “Prebiotic Effects: Metabolic and Health Benefits”. British Journal of Nutrition 104, suppl. 2 (2010): S1–63.